Sven Löffeler

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Venues

Scandinavian journal of urology

BJU international

British journal of cancer

Prostate cancer and prostatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Sven Löffeler, Helena Bertilsson, Christoph Müller, Kirsti Aas, Hege Sagstuen Haugnes, Bjørg Aksnessæther, Maiju Pesonen, Kristian Thon, Torgrim Tandstad, Teemu Murtola, Mads Hvid Poulsen, Tobias Nordström, Maria Nyre Vigmostad, Fredrik Ottosson, Karin Holmsten, Ola Christiansen, Marit Slaaen, Erik Skaaheim Haug, Anne Holck Storås, Lars Asphaug, Antti Sakari Rannikko, Klaus Brasso, null null
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P). BJU international 133 (6) (2024)
Karolina Cyll, Erik Skaaheim Haug, Manohar Pradhan, Ljiljana Vlatkovic, Birgitte Carlsen, Sven Löffeler, Wanja Kildal, Karin Skogstad, Frida Hauge Torkelsen, Rolf Anders Syvertsen, Hanne A Askautrud, Knut Liestøl, Andreas Kleppe, Håvard E Danielsen
DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillance. British journal of cancer (2024)
Karolina Cyll, Erik Skaaheim Haug, Manohar Pradhan, Ljiljana Vlatkovic, Birgitte Carlsen, Sven Löffeler, Wanja Kildal, Karin Skogstad, Frida Hauge Torkelsen, Rolf Anders Syvertsen, Hanne A Askautrud, Knut Liestøl, Andreas Kleppe, Håvard E Danielsen
DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillance. British journal of cancer 131 (5) (2024)
Sven Löffeler, Helena Bertilsson, Christoph Müller, Kirsti Aas, Hege Sagstuen Haugnes, Bjørg Aksnessaether, Maiju Pesonen, Kristian Thon, Torgrim Tandstad, Teemu Murtola, Mads Hvid Poulsen, Tobias Nordström, Maria Nyre Vigmostad, Fredrik Ottosson, Karin Holmsten, Ola Christiansen, Marit Slaaen, Erik Skaaheim Haug, Anne Holck Storås, Lars Asphaug, Antti Sakari Rannikko, Klaus Brasso, null null
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P). BJU international (2024)
Sven Löffeler, Helena Bertilsson, Christoph Müller, Kirsti Aas, Hege Sagstuen Haugnes, Bjørg Aksnessæther, Maiju Pesonen, Kristian Thon, Torgrim Tandstad, Teemu Murtola, Mads Hvid Poulsen, Tobias Nordström, Maria Nyre Vigmostad, Fredrik Ottosson, Karin Holmsten, Ola Christiansen, Marit Slaaen, Erik Skaaheim Haug, Anne Holck Storås, Lars Asphaug, Antti Sakari Rannikko, Klaus Brasso, null null
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P). BJU international 133 (6) (2024)
Karol Axcrona, Sven Löffeler
A Norwegian perspective on the Swedish national guidelines on prostate cancer for non-metastatic disease. Scandinavian journal of urology 56 (4) (2022)
Aino Siltari, Jarno Riikonen, Juha Koskimäki, Tomi Pakarainen, Otto O Ettala, Peter Boström, Heikki Seikkula, Andres Kotsar, Teuvo Tammela, Mika Helminen, Paavo V Raittinen, Terho Lehtimäki, Mikkel Fode, Peter Østergren, Michael Borre, Antti Rannikko, Timo Marttila, Arto Salonen, Hanna Ronkainen, Sven Löffeler, Teemu J Murtola
Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol. BMJ open 12 (4) (2022)
Sven Löffeler, Adrian Halland, Haris Fawad, Christian Beisland, Erik S Haug
Non-metastatic prostate cancer: rationale for conservative treatment and impact on disease-related morbidity and mortality in the elderly. Scandinavian journal of urology 54 (2) (2020)
Hari T Vigneswaran, Thorgerdur Palsdottir, Henrik Olsson, Erik S Haug, Wolfgang Picker, Sven Löffeler, Henrik Grönberg, Martin Eklund, Tobias Nordström
Biomarker discrimination and calibration with MRI-targeted biopsies: an analysis with the Stockholm3 test. Prostate cancer and prostatic diseases 24 (2) (2020)
Sven Löffeler, Adrian Halland, Harald Weedon-Fekjær, Anastasia Nikitenko, Christian Lycke Ellingsen, Erik Skaaheim Haug
High Norwegian prostate cancer mortality: evidence of over-reporting. Scandinavian journal of urology 52 (2) (2018)

Sven Löffeler.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sven Löffeler